| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 6e-08 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |